ADICET BIO INC (ACET) Stock Balance Sheet
NASDAQ:ACET - US0070021086 - Common Stock
0.7203 USD
+0.01 (+1%)
0.73 USD
+0.01 (+1.35%)
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 28.13M | 56.49M | 159.71M | 257.70M | 277.50M | |||
| Marketable Securities | 122.31M | 119.81M | N/A | N/A | 0.00 | |||
| Receivables | N/A | N/A | 0.00 | 400.00K | 200.00K | |||
| Other Current Assets | 3.12M | 3.83M | 2.56M | 2.90M | 4.70M | |||
| Total Current Assets | 153.56M | 180.14M | 162.27M | 261.00M | 282.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 34.49M | 36.75M | 44.20M | 49.00M | 35.00M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 0.00 | |||
| Goodwill | N/A | N/A | 0.00 | 19.50M | 19.50M | |||
| Intangibles | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 3.22M | 3.33M | 822.00K | 1.20M | 2.00M | |||
| Total Non-Current Assets | 37.71M | 40.08M | 45.02M | 69.70M | 56.50M | |||
| TOTAL ASSETS | 191.27M | 220.22M | 207.29M | 330.70M | 338.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 12.04M | 14.56M | 16.66M | 15.30M | 8.20M | |||
| Accounts Payable | 4.40M | 4.83M | 2.63M | 4.40M | 3.30M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 4.80M | |||
| Total Current Liabilities | 16.45M | 19.39M | 19.29M | 19.70M | 16.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | 13.38M | 14.22M | 17.83M | 18.60M | 19.50M | |||
| Total Non-Current Liabilities | 13.38M | 14.22M | 17.83M | 18.70M | 19.50M | |||
| TOTAL LIABILITIES | 29.82M | 33.61M | 37.12M | 38.40M | 35.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -526.11M | -497.89M | -380.77M | -238.10M | -168.30M | |||
| Additional Paid In Capital | 687.55M | 684.48M | 550.94M | 530.40M | 471.40M | |||
| Common Shares | 8.00K | 8.00K | 4.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -9.00K | 16.00K | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 82.71M | 82.57M | 43.27M | 43.00M | 39.70M | |||
| Tangible Book Value per Share | 1.95 | 2.26 | 3.93 | 6.34 | 7.14 | |||
| Total Shareholders' Equity | 161.45M | 186.61M | 170.18M | 292.30M | 303.10M | |||
| TOTAL LIABILITIES AND EQUITY | 191.27M | 220.22M | 207.29M | 330.70M | 338.90M | |||
| Statistics | ||||||||
| Current Ratio | 9.34 | 9.29 | 8.41 | 13.25 | 17.33 | |||
| Return On Assets (ROA) | -61.23% | -53.13% | -68.82% | -21.10% | -18.29% | |||
| Return On Equity (ROE) | -72.54% | -62.70% | -83.83% | -23.88% | -20.46% | |||
All data in USD , ROIC based on taxRate of 0.21